Clinical Stage I Esophageal Adenocarcinoma AJCC v8

specific

Stage II includes: IIA: T1, N1, M0; IIB: T2, N0, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)

23

Centers

21

Active Trials

Cancer Funding

Top Centers for Clinical Stage I Esophageal Adenocarcinoma AJCC v8(23)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
54.1
2
NCI Comprehensive
Active Research Program
54.1
3
NCI Comprehensive
Active Research Program
54.1
4
NCI Comprehensive
Active Research Program
54.1
5
NCI Comprehensive
Active Research Program
54.1
6
NCI Comprehensive
Active Research Program
54.1
754.1
8
NCI Comprehensive
Active Research Program
54.1
9
NCI Comprehensive
Active Research Program
54.1
10
NCI Comprehensive
Active Research Program
54.1
11
NCI Clinical
Active Research Program
54.1
12
NCI Comprehensive
Active Research Program
54.1
13
Active Research Program
54.1
14
Active Research Program
54.1
15
Active Research Program
54.1
16
Active Research Program
54.1
17
NCI Comprehensive
Active Research Program
54.1
18
Active Research Program
54.1
19
Active Research Program
54.1
20
Active Research Program
54.1
21
Active Research Program
54.1
22
NCI Comprehensive
31.6
23
NCI Comprehensive
31.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →